| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/17/2001 | US6218149 Altering affinity of antibody for antigen by deleting dna encoding a carbohydrate recognition site from variable domain of antibody, expressing mutagenized gene, measuring affinity of altered antibody and comparing to control |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | US6218146 MTS2 gene |
| 04/17/2001 | US6218145 Bacterial expression systems based on plastic or mitochondrial promoter combinations |
| 04/17/2001 | US6218141 Assembling expression vector using defined nucleotide sequence coding for protein, transforming host cell, then expressing, isolating, and purifying protein |
| 04/17/2001 | US6218140 Enhancer for eukaryotic expression systems |
| 04/17/2001 | US6218139 Modified yeast strain with acetyl-coenzyme a pregnenolone acetyltransferase eliminated, resulting in stabilization of beta-hydroxy steroids |
| 04/17/2001 | US6218137 Compounds, compositions and methods for generating chemiluminescene with phosphatase enzymes |
| 04/17/2001 | US6218136 Methods of the identification of pharmaceutically active compounds |
| 04/17/2001 | US6218133 Materials and methods for detection and treatment of immune system dysfunctions |
| 04/17/2001 | US6218131 Diagnosis by detecting presence of protein of defined amino acid sequence in sample |
| 04/17/2001 | US6218125 Nucleotide sequences; diagnosis; primers and probes used in strand displacement amplification |
| 04/17/2001 | US6218123 Construction of normalized cDNA libraries from eucaryotic cells |
| 04/17/2001 | US6218122 Measuring abundances of cell components for a diagnostic profile, measuring abundances of cell components in analogous subjects for response profiles, and determining interpolated response profiles which best fit diagnostic profile |
| 04/17/2001 | US6218120 Methods for detecting human methylene tetrahydrofolate reductase allelic variants |
| 04/17/2001 | US6218118 Method and mixture reagents for analyzing the nucleotide sequence of nucleic acids by mass spectrometry |
| 04/17/2001 | US6218115 Nucleotide sequence; recombinant production of cyclin protein; hybridization probes; diagnosis of or screening for cancer and immune disorders; anticarcinogenic agents |
| 04/17/2001 | US6218113 Human protein kinase C inhibitor |
| 04/17/2001 | US6218111 Reagent which is an analyte moiety linked to a tag of at least two reporter groups used for detection by mass spectrometry; the reporter groups identify analyte residue and its position in analyte moiety; screening of libraries |
| 04/17/2001 | US6218107 Compositions and methods for detecting the presence of Mycobacterium kansassii |
| 04/17/2001 | US6218104 Method of detection of carcinogenic human papillomavirus |
| 04/17/2001 | US6217912 Polyester analogue of poly-L-lysine as a soluble, biodegradable gene delivery carrier |
| 04/17/2001 | US6217882 Inserting heterogeneity nucleotide sequence |
| 04/17/2001 | US6217872 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide |
| 04/17/2001 | US6217870 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 04/17/2001 | US6217869 Administering antibody, antigen, ligand complex |
| 04/17/2001 | US6217868 Polypeptides |
| 04/17/2001 | US6217864 Method for targeted degradation of intracellular proteins in vivo or ex vivo |
| 04/17/2001 | US6217863 Rationally designed polysaccharide lyases derived from heparinase I |
| 04/17/2001 | US6217861 pneumococcus; use as drug target for drug screening antibiotics |
| 04/17/2001 | US6217860 Supplying adenoviral vector into tumor |
| 04/17/2001 | US6217859 Orally administering genetic engineered bacteria |
| 04/17/2001 | US6217857 Isolated polypeptide |
| 04/17/2001 | CA2210506C Thermostable dna polymerase from bacillus pallidus |
| 04/17/2001 | CA2207507C Detection of nucleic acids using g-quartets |
| 04/17/2001 | CA2205892C Mutant prenyl diphosphate synthase |
| 04/17/2001 | CA2164941C Salmonella identification by the polymerase chain reaction |
| 04/17/2001 | CA2155089C Nucleic acid sequence encoding trypsin-like enzyme and process for producing the enzyme |
| 04/17/2001 | CA2131355C Production of a single-gene-encoded immunoglobulin |
| 04/17/2001 | CA2125985C Stem cell inhibiting proteins |
| 04/17/2001 | CA2087436C Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 04/17/2001 | CA2071536C Triple helix formation in oligonucleotide therapy |
| 04/17/2001 | CA2071483C Oligonucleotide analogs with novel linkages |
| 04/13/2001 | CA2321260A1 Oral immunology using plant product containing hepatitis surface antigen |
| 04/13/2001 | CA2320741A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/13/2001 | CA2320518A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/12/2001 | WO2001025793A2 Diagnosis of coeliac disease using a gliadin epitope |
| 04/12/2001 | WO2001025792A1 Assaying in vivo t-cell response upon dna vaccination |
| 04/12/2001 | WO2001025492A1 Human antibodies |
| 04/12/2001 | WO2001025491A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 04/12/2001 | WO2001025490A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 04/12/2001 | WO2001025488A2 Method for enrichment of natural antisense messenger rna |
| 04/12/2001 | WO2001025487A2 Electrochemiluminescence helicase assay |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025483A2 Compositions for dna amplification, synthesis, and mutagenesis |
| 04/12/2001 | WO2001025480A2 Dna sequencing method |
| 04/12/2001 | WO2001025478A1 A method of increasing the specificity of oxy-lna oligonucleotides |
| 04/12/2001 | WO2001025470A1 Cellulose films for screening |
| 04/12/2001 | WO2001025469A2 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | WO2001025468A1 High-throughput screening of expressed dna libraries in filamentous fungi |
| 04/12/2001 | WO2001025466A1 Producer cell for the production of retroviral vectors |
| 04/12/2001 | WO2001025465A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | WO2001025464A1 Materials and methods for simplified aav production |
| 04/12/2001 | WO2001025463A1 Recombinant adenoviruses preparation and adenovirus banks |
| 04/12/2001 | WO2001025462A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 04/12/2001 | WO2001025461A1 Utrophin gene promoter |
| 04/12/2001 | WO2001025460A2 Compositions and methods for plant genetic modification |
| 04/12/2001 | WO2001025459A1 Vectors for transforming plants |
| 04/12/2001 | WO2001025458A1 Novel class of proteins and uses thereof for plant resistance to various pathogenic agents |
| 04/12/2001 | WO2001025457A2 Gmp synthetase derived from plants |
| 04/12/2001 | WO2001025456A2 Method for production of proteinaceous substances |
| 04/12/2001 | WO2001025455A2 Promoter for regulating expression of foreign genes |
| 04/12/2001 | WO2001025454A2 Method for regulating transcription of foreign genes in the presence of nitrogen |
| 04/12/2001 | WO2001025453A2 Plant fatty acid desaturases and alleles therefor |
| 04/12/2001 | WO2001025452A1 Targeted gene therapy |
| 04/12/2001 | WO2001025451A2 Cloning vectors |
| 04/12/2001 | WO2001025450A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | WO2001025449A2 Novel immobilizable amylosucrase, the use thereof and method for producing poly(1,4-alpha-glucan) |
| 04/12/2001 | WO2001025448A1 Adenylate cyclase |
| 04/12/2001 | WO2001025447A1 Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 04/12/2001 | WO2001025446A1 Dna encoding prost 07 polypeptide |
| 04/12/2001 | WO2001025445A1 Fibrinolytically active polypeptide |
| 04/12/2001 | WO2001025444A2 Novel human phosphodiesterase zcytor13 |
| 04/12/2001 | WO2001025443A1 Mannose isomerase gene |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025441A2 Tumour-specific vector for gene therapy |
| 04/12/2001 | WO2001025440A1 C3 binding polypeptide of streptococcus agalactiae, group b streptococcus |
| 04/12/2001 | WO2001025439A1 Plant seed endosperm-specific promoter |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025436A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | WO2001025435A2 In vivo treatment of joint disease using interleukin-1 receptor antagonists |
| 04/12/2001 | WO2001025434A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | WO2001025432A2 Histamine receptor |
| 04/12/2001 | WO2001025431A1 Primate, particularly human, vomeronasal-like receptor |
| 04/12/2001 | WO2001025430A2 Novel human membrane proteins |
| 04/12/2001 | WO2001025429A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 04/12/2001 | WO2001025428A1 A novel human leptin homolog |
| 04/12/2001 | WO2001025427A1 Shear stress-response dna |